<?xml version="1.0" encoding="UTF-8"?>
<eudamedExport entity="devices">
  <row>
    <udiDi>08594161370512</udiDi>
    <basicUdiDi>B-08594161370512</basicUdiDi>
    <tradeName>ENTEROSGEL®</tradeName>
    <deviceName>ENTEROSGEL</deviceName>
    <manufacturerName>Bioline Products s.r.o.</manufacturerName>
    <manufacturerSrn>CZ-MF-000034917</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>G0401</emdnCode>
    <emdnDescription>ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>N/A</reference>
    <placedOnMarketCountry>Estonia</placedOnMarketCountry>
    <lastUpdated>2026-07-07T22:46:23.101Z</lastUpdated>
  </row>
  <row>
    <udiDi>08594161370468</udiDi>
    <basicUdiDi>B-08594161370468</basicUdiDi>
    <tradeName>ENTEROSGEL®</tradeName>
    <deviceName>ENTEROSGEL</deviceName>
    <manufacturerName>Bioline Products s.r.o.</manufacturerName>
    <manufacturerSrn>CZ-MF-000034917</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>G0401</emdnCode>
    <emdnDescription>ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS</emdnDescription>
    <deviceStatus>AB pazarı için değil</deviceStatus>
    <reference>N/A</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-07T22:46:22.292Z</lastUpdated>
  </row>
  <row>
    <udiDi>08594161370451</udiDi>
    <basicUdiDi>B-08594161370451</basicUdiDi>
    <tradeName>ENTEROSGEL®</tradeName>
    <deviceName>ENTEROSGEL</deviceName>
    <manufacturerName>Bioline Products s.r.o.</manufacturerName>
    <manufacturerSrn>CZ-MF-000034917</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>G0401</emdnCode>
    <emdnDescription>ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS</emdnDescription>
    <deviceStatus>AB pazarı için değil</deviceStatus>
    <reference>N/A</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-07T22:46:21.490Z</lastUpdated>
  </row>
  <row>
    <udiDi>08594161370444</udiDi>
    <basicUdiDi>B-08594161370444</basicUdiDi>
    <tradeName>ENTEROSGEL®</tradeName>
    <deviceName>ENTEROSGEL</deviceName>
    <manufacturerName>Bioline Products s.r.o.</manufacturerName>
    <manufacturerSrn>CZ-MF-000034917</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>G0401</emdnCode>
    <emdnDescription>ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS</emdnDescription>
    <deviceStatus>AB pazarı için değil</deviceStatus>
    <reference>N/A</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-07T22:46:20.689Z</lastUpdated>
  </row>
  <row>
    <udiDi>08594161370277</udiDi>
    <basicUdiDi>B-08594161370277</basicUdiDi>
    <tradeName>ENTEROSGEL®</tradeName>
    <deviceName>ENTEROSGEL</deviceName>
    <manufacturerName>Bioline Products s.r.o.</manufacturerName>
    <manufacturerSrn>CZ-MF-000034917</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>G0401</emdnCode>
    <emdnDescription>ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>N/A</reference>
    <placedOnMarketCountry>Czechia</placedOnMarketCountry>
    <lastUpdated>2026-07-07T22:46:16.677Z</lastUpdated>
  </row>
  <row>
    <udiDi>08594161370253</udiDi>
    <basicUdiDi>B-08594161370253</basicUdiDi>
    <tradeName>ENTEROSGEL®</tradeName>
    <deviceName>ENTEROSGEL</deviceName>
    <manufacturerName>Bioline Products s.r.o.</manufacturerName>
    <manufacturerSrn>CZ-MF-000034917</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>G0401</emdnCode>
    <emdnDescription>ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS</emdnDescription>
    <deviceStatus>AB pazarı için değil</deviceStatus>
    <reference>N/A</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-07T22:46:15.883Z</lastUpdated>
  </row>
  <row>
    <udiDi>08594161370239</udiDi>
    <basicUdiDi>B-08594161370239</basicUdiDi>
    <tradeName>ENTEROSGEL®</tradeName>
    <deviceName>ENTEROSGEL</deviceName>
    <manufacturerName>Bioline Products s.r.o.</manufacturerName>
    <manufacturerSrn>CZ-MF-000034917</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>G0401</emdnCode>
    <emdnDescription>ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>N/A</reference>
    <placedOnMarketCountry>Estonia</placedOnMarketCountry>
    <lastUpdated>2026-07-07T22:46:15.083Z</lastUpdated>
  </row>
  <row>
    <udiDi>08594161370222</udiDi>
    <basicUdiDi>B-08594161370222</basicUdiDi>
    <tradeName>ENTEROSGEL®</tradeName>
    <deviceName>ENTEROSGEL</deviceName>
    <manufacturerName>Bioline Products s.r.o.</manufacturerName>
    <manufacturerSrn>CZ-MF-000034917</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>G0401</emdnCode>
    <emdnDescription>ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>N/A</reference>
    <placedOnMarketCountry>Poland</placedOnMarketCountry>
    <lastUpdated>2026-07-07T22:46:14.276Z</lastUpdated>
  </row>
  <row>
    <udiDi>08594161370215</udiDi>
    <basicUdiDi>B-08594161370215</basicUdiDi>
    <tradeName>ENTEROSGEL®</tradeName>
    <deviceName>ENTEROSGEL</deviceName>
    <manufacturerName>Bioline Products s.r.o.</manufacturerName>
    <manufacturerSrn>CZ-MF-000034917</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>G0401</emdnCode>
    <emdnDescription>ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>N/A</reference>
    <placedOnMarketCountry>Netherlands</placedOnMarketCountry>
    <lastUpdated>2026-07-07T22:46:09.486Z</lastUpdated>
  </row>
  <row>
    <udiDi>08594161370208</udiDi>
    <basicUdiDi>B-08594161370208</basicUdiDi>
    <tradeName>ENTEROSGEL®</tradeName>
    <deviceName>ENTEROSGEL</deviceName>
    <manufacturerName>Bioline Products s.r.o.</manufacturerName>
    <manufacturerSrn>CZ-MF-000034917</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>G0401</emdnCode>
    <emdnDescription>ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>N/A</reference>
    <placedOnMarketCountry>Slovenia</placedOnMarketCountry>
    <lastUpdated>2026-07-07T22:46:08.677Z</lastUpdated>
  </row>
  <row>
    <udiDi>08594161370130</udiDi>
    <basicUdiDi>B-08594161370130</basicUdiDi>
    <tradeName>ENTEROSGEL®</tradeName>
    <deviceName>ENTEROSGEL</deviceName>
    <manufacturerName>Bioline Products s.r.o.</manufacturerName>
    <manufacturerSrn>CZ-MF-000034917</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>G0401</emdnCode>
    <emdnDescription>ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>N/A</reference>
    <placedOnMarketCountry>Poland</placedOnMarketCountry>
    <lastUpdated>2026-07-07T22:46:07.883Z</lastUpdated>
  </row>
  <row>
    <udiDi>08594161370116</udiDi>
    <basicUdiDi>B-08594161370116</basicUdiDi>
    <tradeName>ENTEROSGEL®</tradeName>
    <deviceName>ENTEROSGEL</deviceName>
    <manufacturerName>Bioline Products s.r.o.</manufacturerName>
    <manufacturerSrn>CZ-MF-000034917</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>G0401</emdnCode>
    <emdnDescription>ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS</emdnDescription>
    <deviceStatus>AB pazarı için değil</deviceStatus>
    <reference>N/A</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-07T22:46:07.160Z</lastUpdated>
  </row>
  <row>
    <udiDi>08594161370109</udiDi>
    <basicUdiDi>B-08594161370109</basicUdiDi>
    <tradeName>ENTEROSGEL®</tradeName>
    <deviceName>ENTEROSGEL</deviceName>
    <manufacturerName>Bioline Products s.r.o.</manufacturerName>
    <manufacturerSrn>CZ-MF-000034917</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>G0401</emdnCode>
    <emdnDescription>ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>N/A</reference>
    <placedOnMarketCountry>Slovenia</placedOnMarketCountry>
    <lastUpdated>2026-07-07T22:46:03.070Z</lastUpdated>
  </row>
  <row>
    <udiDi>08594161370055</udiDi>
    <basicUdiDi>B-08594161370055</basicUdiDi>
    <tradeName>ENTEROSGEL®</tradeName>
    <deviceName>ENTEROSGEL</deviceName>
    <manufacturerName>Bioline Products s.r.o.</manufacturerName>
    <manufacturerSrn>CZ-MF-000034917</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>G0401</emdnCode>
    <emdnDescription>ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>N/A</reference>
    <placedOnMarketCountry>Czechia</placedOnMarketCountry>
    <lastUpdated>2026-07-07T22:46:02.291Z</lastUpdated>
  </row>
</eudamedExport>